Targeted Therapies
Cross-source consensus on Targeted Therapies from 1 sources and 4 claims.
1 sources · 4 claims
Risks & contraindications
Comparisons
Evidence quality
Highlighted claims
- Cytotoxic agents were the most frequently included, registered, and locally produced subclass of anticancer medicines. — Determinants of access to anticancer medicines in South Asia: a multimethod study
- Targeted therapies were poorly represented in national lists and remained a major access gap. — Determinants of access to anticancer medicines in South Asia: a multimethod study
- Headline registration numbers can obscure poor access to newer cancer therapies because older cytotoxic medicines dominate registration patterns. — Determinants of access to anticancer medicines in South Asia: a multimethod study
- High medicine costs and limited public budgets discouraged countries from listing high-cost and innovative agents. — Determinants of access to anticancer medicines in South Asia: a multimethod study